resveratrol has been researched along with beta-Thalassemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foong, WC; Ho, JJ; Lau, DS; Loh, CK | 1 |
| Bordbar, M; Eshghi, P; Haghpanah, S; Hoormand, M; Karimi, M; Zarei, T; Zekavat, O | 1 |
| An, X; Anne, J; Bertoldi, M; Brugnara, C; Cappellini, MD; De Falco, L; De Franceschi, L; Franco, SS; Ghaffari, S; Iolascon, A; Matte', A; Michan, S; Mohandas, N; Rimmelé, P; Siciliano, A; Sinclair, DA; Zoratti, E | 1 |
| Bianchi, N; Borgatti, M; Breveglieri, G; Brognara, E; Fibach, E; Finotti, A; Gambari, R; Lampronti, I; Lipucci di Paola, M; Prus, E; Salvatori, F; Zuccato, C | 1 |
1 review(s) available for resveratrol and beta-Thalassemia
| Article | Year |
|---|---|
Foetal haemoglobin inducers for reducing blood transfusion in non-transfusion-dependent beta-thalassaemias.
Topics: beta-Thalassemia; Blood Transfusion; Fetal Hemoglobin; Humans; Hydroxyurea; Resveratrol | 2023 |
2 trial(s) available for resveratrol and beta-Thalassemia
| Article | Year |
|---|---|
Efficacy and safety of resveratrol, an oral hemoglobin F-augmenting agent, in patients with beta-thalassemia intermedia.
Topics: Administration, Oral; Adolescent; Adult; Alkaloids; Benzodioxoles; beta-Thalassemia; Double-Blind Method; Female; Fetal Hemoglobin; Humans; Iran; Male; Piperidines; Polyunsaturated Alkamides; Resveratrol; Stilbenes; Treatment Outcome; Up-Regulation; Young Adult | 2018 |
Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice.
Topics: Animals; beta-Thalassemia; Catalase; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erythrocytes; Erythropoiesis; Forkhead Box Protein O3; Forkhead Transcription Factors; Humans; Male; Mice; Peroxiredoxins; Resveratrol; Stilbenes | 2014 |
1 other study(ies) available for resveratrol and beta-Thalassemia
| Article | Year |
|---|---|
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients.
Topics: Antioxidants; beta-Globins; beta-Thalassemia; Cell Differentiation; Cell Proliferation; Erythroid Cells; Erythroid Precursor Cells; Fetal Hemoglobin; gamma-Globins; Gene Expression Regulation; Humans; K562 Cells; Oxidation-Reduction; Promoter Regions, Genetic; Protein Biosynthesis; Proteomics; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Stilbenes; Tissue Donors; Transcription, Genetic | 2012 |